Crucell Reaches Agreement with Sanofi Pasteur on Programs in the Field of Paediatric and Respiratory Vaccines

09-Jul-2010 - Crucell N.V. announced that Crucell and sanofi pasteur reached an agreement on a series of transactions to restructure their long standing partnership. Crucell will waive its right to terminate an existing license agreement between Crucell Switzerland and sanofi pasteur's subsidiary Shantha ...

Shantha Biotechnics awarded large vaccine contracts by United Nations agency

Shantha awarded 2010-2012 contracts for pentavalent vaccine SHAN5™ (DTP, HiB, Hep.B)

03-Sep-2009 - Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced that Shantha Biotechnics was awarded contracts by a United Nations agency for supplies of pentavalent vaccine SHAN5™ (combination vaccine of Diphtheria, Pertussis, Tetanus, Haemophilus influenza B, and Hepatitis B). The ...

Sanofi Pasteur strengthens vaccines position in India through the control of Shantha Biotechnics via Mérieux Alliance

28-Jul-2009 - Sanofi-aventis and Mérieux Alliance announced the signature of a strategic agreement for the acquisition by Sanofi Pasteur of Mérieux Alliance’s French subsidiary ShanH, which owns a majority stake in vaccine company Shantha Biotechnics based in Hyderabad, India. Alain Mérieux will chair the ...